# Studying Partial-agonists for Ethanol and Tobacco Elimination in Russians With HIV (St PETER HIV)

> **NCT02797587** · PHASE2,PHASE3 · COMPLETED · sponsor: **Boston Medical Center** · enrollment: 400 (actual)

## Conditions studied

- HIV Infection
- Alcohol Use
- Smoking

## Interventions

- **DRUG:** Varenicline
- **DRUG:** Cytisine
- **DRUG:** Nicotine Replacement Therapy
- **DRUG:** Varenicline Placebo
- **DRUG:** Cytisine Placebo
- **DRUG:** Nicotine Replacement Therapy Placebo

## Key facts

- **NCT ID:** NCT02797587
- **Lead sponsor:** Boston Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-19
- **Primary completion:** 2020-04-30
- **Final completion:** 2020-12-15
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2020-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02797587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02797587, "Studying Partial-agonists for Ethanol and Tobacco Elimination in Russians With HIV (St PETER HIV)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02797587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*